Shoshana Golden’s Insights

84 total results. Page 1 of 7.

Investigations Blog
DOJ Criminal Division’s Fraud Section 2025 Year in Review Touts Record Takedown, More Corporate Cases, and an Expanded Mission
Alerts
New Draft Guidance Addresses FDA’s Records Access Authority for Cosmetics Under MoCRA
Investigations Blog
DOJ False Claims Act Suit Targets Long Term Care Hospital Chain
Alerts
MoCRA Marches On: FDA Issues Draft Guidance on Mandatory Cosmetic Recalls
Alerts
Federal Court Halts 340B Rebate Model Pilot Program
Alerts
FDA Proposes First New Sunscreen Active Ingredient in Two Decades
Alerts
Four Lessons From Product-Related Defamation Litigation for Pharmaceutical and Life Sciences Companies
Alerts
FDA Withdraws Cosmetics Proposed Rule: Let Us (Not) Talk About Talc
Alerts
CMS Issues 2026 Hospital Outpatient Prospective Payment System Final Rule: Key Takeaways for Pharma
Alerts
Update on CMS 2026 Physician Fee Schedule Final Rule: Key Takeaways for Pharma
Alerts
CMS Issues 2026 Physician Fee Schedule Final Rule: Key Takeaways for Pharma
Investigations Blog
Brothers Convicted in $100 Million HIV Drug Fraud Scheme